AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 15 filers reported holding AMBRX BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,222,775 | -49.3% | 249,190 | -87.1% | 0.21% | -41.9% |
| Q4 2022 | $4,386,982 | +110.2% | 1,932,591 | 0.0% | 0.36% | +61.4% |
| Q3 2022 | $2,087,000 | -59.2% | 1,932,591 | 0.0% | 0.22% | -68.6% |
| Q2 2022 | $5,121,000 | -35.7% | 1,932,591 | 0.0% | 0.71% | +3.3% |
| Q1 2022 | $7,962,000 | -54.4% | 1,932,591 | 0.0% | 0.69% | -31.1% |
| Q4 2021 | $17,451,000 | -33.1% | 1,932,591 | 0.0% | 1.00% | -25.3% |
| Q3 2021 | $26,090,000 | -31.1% | 1,932,591 | 0.0% | 1.34% | -40.6% |
| Q2 2021 | $37,879,000 | – | 1,932,591 | – | 2.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,932,591 | $5,121,000 | 0.71% |
| Cormorant Asset Management, LP | 2,486,386 | $6,589,000 | 0.50% |
| Artal Group S.A. | 2,152,291 | $5,704,000 | 0.30% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,491,832 | $3,953,000 | 0.15% |
| Octagon Capital Advisors LP | 122,800 | $325,000 | 0.09% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,027,291 | $5,372,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 19,063 | $51,000 | 0.00% |
| FMR LLC | 3,857,679 | $10,223,000 | 0.00% |
| Renaissance Technologies | 11,000 | $29,000 | 0.00% |
| UBS Group AG | 242 | $1,000 | 0.00% |